European Federation of Pharmaceutical Industries & Associations: Patients and Society Set to Benefit From Innovation Which Could 'Alleviate Significant Global Disease Burden'
December 10, 2024
December 10, 2024
BRUSSELS, Belgium, Dec. 10 (TNSres) -- The European Federation of Pharmaceutical Industries and Associations issued the following news release on Dec. 9, 2024:
EFPIA has today published its 2024 Pipeline Review - Innovation for unmet need. The report highlights a range of factors contributing to a major shift in the types of diseases impacting society. These include an aging population, climate change, lifestyle choices and antimicrobial resistance (AMR).
It shows that . . .
EFPIA has today published its 2024 Pipeline Review - Innovation for unmet need. The report highlights a range of factors contributing to a major shift in the types of diseases impacting society. These include an aging population, climate change, lifestyle choices and antimicrobial resistance (AMR).
It shows that . . .